SOURCE: HealthSonix, Inc.

August 22, 2007 15:40 ET

HealthSonix Selects Synergy Management as International Marketing Consultant

IRVINE, CA--(Marketwire - August 22, 2007) - HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it has retained Synergy Management Group to promote its new line of products and services. With regional offices in Canada, and Associates across North America, Asia and the EU, Synergy's family of professional Business and Economic Development Consultants has served the private and public sectors, and government, for over twenty years.

"Synergy brands, develops consumer awareness and creates market interest, including through editorial media placements, in products ranging from technology to consumer items," stated Mr. Jay Silverberg, President and CEO of Synergy. "Our team," he continued, "has served a number of Fortune 500 companies, in national and international markets. We all feel strongly that HealthSonix, and ZingiberRx should have a significant impact in the marketplace."

"We are indeed pleased to be working with Synergy and feel confident that our company will be in an even stronger position to implement its business plan for 2008 and beyond," stated Dieter Doederlein, Vice President, Corporate Development at HealthSonix. "The cornerstone of our growth plan is the international launch of ZingiberRX, pain relieving cream and our next-generation enSonix@home, sound pressure wave technology and the related delivery systems. This requires a focused and aggressive marketing team that is familiar with the challenges of new, groundbreaking technology. Synergy certainly met all our selection criteria."

"We feel that HealthSonix has a medical breakthrough that will have a worldwide impact, and are looking forward to being part of their ambitious growth plans," said Jay Silverberg, President & CEO, Synergy Management Group Ltd. "Our depth of experience in marketing leading-edge technology was a factor and the fact that our Technology team brings together a wealth of strategic media relations experience to an ever-growing and highly diverse practice was viewed as a key asset and good fit for this exciting assignment," said Mr. Silverman.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core products are based on proprietary, patent pending medical technologies that use sound pressure waves to stimulate soft tissue, muscles and sensory and mechanoreceptors in the human body to relieve pain. All treatments and products are safe, non-invasive, and have no known side effects.

More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information